Expression and Methylation Status of DACT2 Gene in Esophageal Squamous Cell Carcinoma

刘磊,周珍,邝刚,沈素朋,梁佳,郭炜,郭艳丽,董稚明

DOI: https://doi.org/10.11735/j.issn.1004-0242.2017.04.A012

2017-01-01

Abstract:[Purpose] To investigate the expression and methylation status of DACT2 gene in esophageal squamous cell carcinoma(ESCC).[Methods] The mRNA expression and methylation status of DACT2 gene in esophageal cancer cell lines(TE1,TE13,T.TN,Eca109) treated or untreated with DNA methyltransferase inhibitor 5-aza-2'-detoxycytidine(5-aza-dC),and in ESCC tissues and corresponding non-cancerous tissues were detected by reverse transcription polymerase chain reaction (RT-PCR) and methylation specific PCR (MSP),respectively.[Results] Relatively low expression and hypermethylation of DACT2 was detected in 4 esophageal cancer cell lines untreated with 5-aza-dC.After treatment with 5-aza-dC,the expression of DACT2 was enhanced,and the methylation status of DACT2 was reversed in esophageal cancer cell lines.The expression of DACT2 in ESCC tumor tissues was significantly reduced compared to corresponding non-cancerous tissues (0.66±0.53 vs 0.95±0.64,t=-2.43,P=0.018),and was associated with lymph node metastasis(t=-2.030,P=0.048).The methylation frequency of DACT2 promoter in ESCC tissues was significantly higher than that in corresponding normal tissues(50.0％ vs 21.1％,x2=9.439,P=0.002),and was associated with TNM stage,pathological differentiation and lymph node metastasis (all P＜0.05).The expressions of DACT2 in ESCC tumor tissues with methylation of the gene was significantly lower than that in tumor tissues with unmethylation of the gene (0.46±0.32 vs 0.78±0.61,t=-2.341,P=0.023).[Conclusion] Aberrant low expression of DACT2 is closely related to the occurrence and development of ESCC,and promoter methylation may be one of the mechanisms for inactivation of DACT2 in ESCC.